Nonilex<p>~30% of <a href="https://masto.ai/tags/pharmaceutical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharmaceutical</span></a> imports in 2023 were ingredients used in US manufacturing & then exported or sold in the <a href="https://masto.ai/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a>.</p><p><a href="https://masto.ai/tags/Tariffs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Tariffs</span></a> on these would raise domestic production costs by 4.1% & reduce the global competitiveness of US-made <a href="https://masto.ai/tags/drugs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>drugs</span></a>, the report said.</p><p>~25% of US pharmaceutical output is exported, which totalled $101B in 2023. EY said a portion of the 490k export-related <a href="https://masto.ai/tags/jobs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>jobs</span></a> in the industry could be at risk if higher input <a href="https://masto.ai/tags/costs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>costs</span></a> weaken foreign demand for US <a href="https://masto.ai/tags/medicines" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>medicines</span></a>.</p><p><a href="https://masto.ai/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Trump</span></a></p>